메뉴 건너뛰기




Volumn 27, Issue 3, 2012, Pages 929-936

The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment

Author keywords

Acute kidney injury; EPO; HIF; Hypoxia; Protection

Indexed keywords

2 (1 CHLORO 4 HYDROXYISOQUINOLINE 3 CARBOXAMIDO)ACETATE; CREATININE; ENZYME INHIBITOR; ERYTHROPOIETIN; HYPOXIA INDUCIBLE FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

EID: 84860505643     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr379     Document Type: Article
Times cited : (72)

References (43)
  • 1
    • 39349105563 scopus 로고    scopus 로고
    • The RIFLE criteria and mortality in acute kidney injury: A systematic review
    • Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 2008; 73: 538-546
    • (2008) Kidney Int , vol.73 , pp. 538-546
    • Ricci, Z.1    Cruz, D.2    Ronco, C.3
  • 2
    • 75849163295 scopus 로고    scopus 로고
    • Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model
    • Bernhardt WM, Gottmann U, Doyon F et al. Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model. Proc Natl Acad Sci U S A 2009; 106: 21276-21281
    • (2009) Proc Natl Acad Sci U S A , vol.106 , pp. 21276-21281
    • Bernhardt, W.M.1    Gottmann, U.2    Doyon, F.3
  • 3
    • 33745820018 scopus 로고    scopus 로고
    • Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure
    • Bernhardt WM, Campean V, Kany S et al. Preconditional activation of hypoxia-inducible factors ameliorates ischemic acute renal failure. J Am Soc Nephrol 2006; 17: 1970-1978
    • (2006) J Am Soc Nephrol , vol.17 , pp. 1970-1978
    • Bernhardt, W.M.1    Campean, V.2    Kany, S.3
  • 4
    • 54149114944 scopus 로고    scopus 로고
    • Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney
    • Rosenberger C, Rosen S, Shina A et al. Activation of hypoxia-inducible factors ameliorates hypoxic distal tubular injury in the isolated perfused rat kidney. Nephrol Dial Transplant 2008; 23: 3472-3478
    • (2008) Nephrol Dial Transplant , vol.23 , pp. 3472-3478
    • Rosenberger, C.1    Rosen, S.2    Shina, A.3
  • 5
    • 38149075003 scopus 로고    scopus 로고
    • Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury
    • Hill P, Shukla D, TranMGet al. Inhibition of hypoxia inducible factor hydroxylases protects against renal ischemia-reperfusion injury. J Am Soc Nephrol 2008; 19: 39-46
    • (2008) J Am Soc Nephrol , vol.19 , pp. 39-46
    • Hill, P.1    Shukla, D.2    Tran, M.G.3
  • 6
    • 40449110083 scopus 로고    scopus 로고
    • HIF activation protects from acute kidney injury
    • Weidemann A, Bernhardt WM, Klanke B et al. HIF activation protects from acute kidney injury. J Am Soc Nephrol 2008; 19: 486-494
    • (2008) J Am Soc Nephrol , vol.19 , pp. 486-494
    • Weidemann, A.1    Bernhardt, W.M.2    Klanke, B.3
  • 7
    • 17944375360 scopus 로고    scopus 로고
    • C. Elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation
    • Epstein AC, Gleadle JM, McNeill LA et al. C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell 2001; 107: 43-54
    • (2001) Cell , vol.107 , pp. 43-54
    • Epstein, A.C.1    Gleadle, J.M.2    McNeill, L.A.3
  • 8
    • 0035834409 scopus 로고    scopus 로고
    • A conserved family of prolyl-4-hydroxylases that modify HIF
    • Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science 2001; 294: 1337-1340
    • (2001) Science , vol.294 , pp. 1337-1340
    • Bruick, R.K.1    McKnight, S.L.2
  • 9
    • 0037097861 scopus 로고    scopus 로고
    • FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxiainducible factor
    • Lando D, Peet DJ, Gorman JJ et al. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxiainducible factor. Genes Dev 2002; 16: 1466-1471
    • (2002) Genes Dev , vol.16 , pp. 1466-1471
    • Lando, D.1    Peet, D.J.2    Gorman, J.J.3
  • 10
    • 70449527373 scopus 로고    scopus 로고
    • Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing
    • Webb JD, Coleman ML, Pugh CW. Hypoxia, hypoxia-inducible factors (HIF), HIF hydroxylases and oxygen sensing. Cell Mol Life Sci 2009; 66: 3539-3554
    • (2009) Cell Mol Life Sci , vol.66 , pp. 3539-3554
    • Webb, J.D.1    Coleman, M.L.2    Pugh, C.W.3
  • 11
    • 78649364332 scopus 로고    scopus 로고
    • Hypoxia-inducible factors and the response to hypoxic stress
    • Majmundar AJ, Wong WJ, Simon MC. Hypoxia-inducible factors and the response to hypoxic stress. Mol Cell 2010; 40: 294-309
    • (2010) Mol Cell , vol.40 , pp. 294-309
    • Majmundar, A.J.1    Wong, W.J.2    Simon, M.C.3
  • 12
    • 0028816847 scopus 로고
    • Purification and characterization of hypoxiainducible factor 1
    • Wang GL, Semenza GL. Purification and characterization of hypoxiainducible factor 1. J Biol Chem 1995; 270: 1230-1237
    • (1995) J Biol Chem , vol.270 , pp. 1230-1237
    • Wang, G.L.1    Semenza, G.L.2
  • 13
    • 0031041377 scopus 로고    scopus 로고
    • Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia
    • Lee PJ, Jiang BH, Chin BY et al. Hypoxia-inducible factor-1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J Biol Chem 1997; 272: 5375-5381
    • (1997) J Biol Chem , vol.272 , pp. 5375-5381
    • Lee, P.J.1    Jiang, B.H.2    Chin, B.Y.3
  • 14
    • 0037108807 scopus 로고    scopus 로고
    • Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor
    • Ivan M, Haberberger T, Gervasi DC et al. Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor. Proc Natl Acad Sci U S A 2002; 99: 13459-13464
    • (2002) Proc Natl Acad Sci U S A , vol.99 , pp. 13459-13464
    • Ivan, M.1    Haberberger, T.2    Gervasi, D.C.3
  • 15
    • 61849134968 scopus 로고    scopus 로고
    • In vivo functions of the prolyl-4-hydroxylase domain oxygen sensors: Direct route to the treatment of anaemia and the protection of ischaemic tissues
    • Katschinski DM. In vivo functions of the prolyl-4-hydroxylase domain oxygen sensors: direct route to the treatment of anaemia and the protection of ischaemic tissues. Acta Physiol (Oxf) 2009; 195: 407-414
    • (2009) Acta Physiol (Oxf) , vol.195 , pp. 407-414
    • Katschinski, D.M.1
  • 16
    • 0141595004 scopus 로고    scopus 로고
    • Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney
    • Yang CW, Li C, Jung JY et al. Preconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidney. FASEB J 2003; 17: 1754-1755
    • (2003) FASEB J , vol.17 , pp. 1754-1755
    • Yang, C.W.1    Li, C.2    Jung, J.Y.3
  • 17
    • 3543097510 scopus 로고    scopus 로고
    • Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion
    • Sharples EJ, Patel N, Brown P et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol 2004; 15: 2115-2124
    • (2004) J Am Soc Nephrol , vol.15 , pp. 2115-2124
    • Sharples, E.J.1    Patel, N.2    Brown, P.3
  • 18
    • 9644297877 scopus 로고    scopus 로고
    • Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia
    • Abdelrahman M, Sharples EJ, McDonald MC et al. Erythropoietin attenuates the tissue injury associated with hemorrhagic shock and myocardial ischemia. Shock 2004; 22: 63-69
    • (2004) Shock , vol.22 , pp. 63-69
    • Abdelrahman, M.1    Sharples, E.J.2    McDonald, M.C.3
  • 19
    • 33645742022 scopus 로고    scopus 로고
    • Protective effect of erythropoietin on renal ischemia and reperfusion injury
    • Ates E, Yalcin AU, Yilmaz S et al. Protective effect of erythropoietin on renal ischemia and reperfusion injury. ANZ J Surg 2005; 75: 1100-1105
    • (2005) ANZ J Surg , vol.75 , pp. 1100-1105
    • Ates, E.1    Yalcin, A.U.2    Yilmaz, S.3
  • 20
    • 4344626952 scopus 로고    scopus 로고
    • Low-dose therapy with the long - Acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure
    • Bahlmann FH, Song R, Boehm SM et al. Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failure. Circulation 2004; 110: 1006-1012
    • (2004) Circulation , vol.110 , pp. 1006-1012
    • Bahlmann, F.H.1    Song, R.2    Boehm, S.M.3
  • 21
    • 65649135802 scopus 로고    scopus 로고
    • Application of a proteolysis/mass spectrometry method for investigating the effects of inhibitors on hydroxylase structure
    • Stubbs CJ, Loenarz C, Mecinovic J et al. Application of a proteolysis/mass spectrometry method for investigating the effects of inhibitors on hydroxylase structure. J Med Chem 2009; 52: 2799-2805
    • (2009) J Med Chem , vol.52 , pp. 2799-2805
    • Stubbs, C.J.1    Loenarz, C.2    Mecinovic, J.3
  • 22
    • 79953891392 scopus 로고    scopus 로고
    • Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors
    • Tian YM, Yeoh KK, Lee MK et al. Differential sensitivity of hypoxia inducible factor hydroxylation sites to hypoxia and hydroxylase inhibitors. J Biol Chem 2011; 286: 13041-13051
    • (2011) J Biol Chem , vol.286 , pp. 13041-13051
    • Tian, Y.M.1    Yeoh, K.K.2    Lee, M.K.3
  • 23
    • 18444380862 scopus 로고    scopus 로고
    • Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys
    • Rosenberger C, Mandriota S, Jurgensen JS et al. Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol 2002; 13: 1721-1732
    • (2002) J Am Soc Nephrol , vol.13 , pp. 1721-1732
    • Rosenberger, C.1    Mandriota, S.2    Jurgensen, J.S.3
  • 25
    • 57149111046 scopus 로고    scopus 로고
    • Physiological basis for the use of erythropoietin in critically ill patients at risk for acute kidney injury
    • Bernhardt WM, Eckardt KU. Physiological basis for the use of erythropoietin in critically ill patients at risk for acute kidney injury. Curr Opin Crit Care 2008; 14: 621-626
    • (2008) Curr Opin Crit Care , vol.14 , pp. 621-626
    • Bernhardt, W.M.1    Eckardt, K.U.2
  • 26
    • 33746137372 scopus 로고    scopus 로고
    • Discovering erythropoietin's extra-hematopoietic functions: Biology and clinical promise
    • Brines M, Cerami A. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Kidney Int 2006; 70: 246-250
    • (2006) Kidney Int , vol.70 , pp. 246-250
    • Brines, M.1    Cerami, A.2
  • 27
    • 0027410945 scopus 로고
    • Co-localization of erythropoietin mRNA and ecto-5'-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin
    • Bachmann S, Le Hir M, Eckardt KU. Co-localization of erythropoietin mRNA and ecto-5'-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietin. J Histochem Cytochem 1993; 41: 335-341
    • (1993) J Histochem Cytochem , vol.41 , pp. 335-341
    • Bachmann, S.1    Le Hir, M.2    Eckardt, K.U.3
  • 28
    • 0027367661 scopus 로고
    • Identification of the renal erythropoietin-producing cells using transgenic mice
    • Maxwell PH, Osmond MK, Pugh CW et al. Identification of the renal erythropoietin-producing cells using transgenic mice. Kidney Int 1993; 44: 1149-1162
    • (1993) Kidney Int , vol.44 , pp. 1149-1162
    • Maxwell, P.H.1    Osmond, M.K.2    Pugh, C.W.3
  • 29
    • 17044378251 scopus 로고    scopus 로고
    • HIF-2alpha regulates murine hematopoietic development in an erythropoietin-dependent manner
    • Scortegagna M, Ding K, Zhang Q et al. HIF-2alpha regulates murine hematopoietic development in an erythropoietin-dependent manner. Blood 2005; 105: 3133-3140
    • (2005) Blood , vol.105 , pp. 3133-3140
    • Scortegagna, M.1    Ding, K.2    Zhang, Q.3
  • 30
    • 9444283176 scopus 로고    scopus 로고
    • Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: Erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells
    • Warnecke C, Zaborowska Z, Kurreck J et al.Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J 2004; 18: 1462-1464
    • (2004) FASEB J , vol.18 , pp. 1462-1464
    • Warnecke, C.1    Zaborowska, Z.2    Kurreck, J.3
  • 31
    • 75749150800 scopus 로고    scopus 로고
    • Hypoxia-inducible factor-2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization
    • Paliege A, Rosenberger C, Bondke A et al. Hypoxia-inducible factor-2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization. Kidney Int 2010; 77: 312-318
    • (2010) Kidney Int , vol.77 , pp. 312-318
    • Paliege, A.1    Rosenberger, C.2    Bondke, A.3
  • 32
    • 34548829081 scopus 로고    scopus 로고
    • HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques
    • Hsieh MM, Linde NS, Wynter A et al. HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques. Blood 2007; 110: 2140-2147
    • (2007) Blood , vol.110 , pp. 2140-2147
    • Hsieh, M.M.1    Linde, N.S.2    Wynter, A.3
  • 33
    • 78649876180 scopus 로고    scopus 로고
    • Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD
    • Bernhardt WM, Wiesener MS, Scigalla P et al. Inhibition of prolyl hydroxylases increases erythropoietin production in ESRD. J Am Soc Nephrol 2010; 21: 2151-2156
    • (2010) J Am Soc Nephrol , vol.21 , pp. 2151-2156
    • Bernhardt, W.M.1    Wiesener, M.S.2    Scigalla, P.3
  • 34
    • 33846883294 scopus 로고    scopus 로고
    • New agents that stimulate erythropoiesis
    • Bunn HF. New agents that stimulate erythropoiesis. Blood 2007; 109: 868-873
    • (2007) Blood , vol.109 , pp. 868-873
    • Bunn, H.F.1
  • 35
    • 33750868502 scopus 로고    scopus 로고
    • Recent advances in erythropoietic agents in renal anemia
    • Macdougall IC. Recent advances in erythropoietic agents in renal anemia. Semin Nephrol 2006; 26: 313-318
    • (2006) Semin Nephrol , vol.26 , pp. 313-318
    • MacDougall, I.C.1
  • 36
    • 36849049298 scopus 로고    scopus 로고
    • Hypoxia and the HIF system in kidney disease
    • Nangaku M, Eckardt KU. Hypoxia and the HIF system in kidney disease. J Mol Med 2007; 85: 1325-1330
    • (2007) J Mol Med , vol.85 , pp. 1325-1330
    • Nangaku, M.1    Eckardt, K.U.2
  • 37
    • 4344675279 scopus 로고    scopus 로고
    • Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo
    • Patel NS, Sharples EJ, Cuzzocrea S et al. Pretreatment with EPO reduces the injury and dysfunction caused by ischemia/reperfusion in the mouse kidney in vivo. Kidney Int 2004; 66: 983-989
    • (2004) Kidney Int , vol.66 , pp. 983-989
    • Patel, N.S.1    Sharples, E.J.2    Cuzzocrea, S.3
  • 38
    • 1042292029 scopus 로고    scopus 로고
    • Erythropoietin protects against ischaemic acute renal injury
    • Vesey DA, Cheung C, Pat B et al. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant 2004; 19: 348-355
    • (2004) Nephrol Dial Transplant , vol.19 , pp. 348-355
    • Vesey, D.A.1    Cheung, C.2    Pat, B.3
  • 39
    • 31544472841 scopus 로고    scopus 로고
    • Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model
    • Spandou E, Tsouchnikas I, Karkavelas G et al. Erythropoietin attenuates renal injury in experimental acute renal failure ischaemic/reperfusion model. Nephrol Dial Transplant 2006; 21: 330-336
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 330-336
    • Spandou, E.1    Tsouchnikas, I.2    Karkavelas, G.3
  • 40
    • 0033029430 scopus 로고    scopus 로고
    • Human, rat, and mouse kidney cells express functional erythropoietin receptors
    • Westenfelder C, Biddle DL, Baranowski RL. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int 1999; 55: 808-820
    • (1999) Kidney Int , vol.55 , pp. 808-820
    • Westenfelder, C.1    Biddle, D.L.2    Baranowski, R.L.3
  • 41
    • 3242772957 scopus 로고    scopus 로고
    • EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney
    • Gong H, Wang W, Kwon TH et al. EPO and alpha-MSH prevent ischemia/reperfusion-induced down-regulation of AQPs and sodium transporters in rat kidney. Kidney Int 2004; 66: 683-695
    • (2004) Kidney Int , vol.66 , pp. 683-695
    • Gong, H.1    Wang, W.2    Kwon, T.H.3
  • 42
    • 79958031337 scopus 로고    scopus 로고
    • High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study
    • Martinez F, Kamar N, Pallet N et al. High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study. Am J Transplant 2010; 10: 1695-1700
    • (2010) Am J Transplant , vol.10 , pp. 1695-1700
    • Martinez, F.1    Kamar, N.2    Pallet, N.3
  • 43
    • 84861156312 scopus 로고    scopus 로고
    • High-Dose Erythropoietin (EPO) and Graft Function after Cadaveric Kidney Transplantation
    • Hafer C, Kielstein JT, Becker T et al. High-Dose Erythropoietin (EPO) and Graft Function after Cadaveric Kidney Transplantation. J Am Soc Nephrol 2010; 21: 810A
    • (2010) J Am Soc Nephrol , vol.21
    • Hafer, C.1    Kielstein, J.T.2    Becker, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.